2014 SABCS Public Thursday
Read More
San Antonio, TX - SABCS 2014 San Antonio Breast Cancer Symposium - Sikov WM discusses S4-05. Impact of intrinsic subtype by PAM50 and other gene signatures on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) or bevacizumab (Bev): CALGB 40603/150709 (Alliance) during GENERAL SESSION 4 here today, Thursday December 11, 2014. during the San Antonio Breast Cancer Symposium being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. Over 7,500 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Photo by © MedMeetingImages/Todd Buchanan 2014 Technical Questions: todd@medmeetingimages.com
